Suppr超能文献

哪些有胃癌家族史的个体急需强化筛查和根除幽门螺杆菌?一项系统评价和荟萃分析。

Which Individuals with Positive Family History of Gastric Cancer Urgently Need Intensive Screening and Eradication of Helicobacter Pylori? A Systematic Review and Meta-Analysis.

作者信息

He Gui, Ji Xuanke, Yan Yali, Wang Kunyan, Song Chunhua, Wang Peng, Ye Hua, Dai Liping, Zhang Jianying, Wang Kaijuan

机构信息

Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China.

Key Laboratory of Tumor Epidemiology of Henan Province, Zhengzhou University, Zhengzhou, China.

出版信息

Iran J Public Health. 2021 Dec;50(12):2384-2396. doi: 10.18502/ijph.v50i12.7922.

Abstract

BACKGROUND

Family history may inform individuals that they are at risk of gastric cancer (GC). However, it is too extensive to conduct intensive screening strategies for all individuals with family history of GC instead of average-risk screening. To establish more precise prevention strategies, accurate risk estimates are necessary for individuals with family history of GC.

METHODS

We searched PubMed, EMBASE and Cochrane for all relevant studies from their inception to May 21, 2020, for cohort and case-control studies investigating the association between family history of GC and its risk. Relative risk (RR) and 95% confidence interval (CI) were pooled from studies using random-effects or fixed effects.

RESULTS

The RR of GC was 2.08 (95% CI=1.86-2.34) in individuals with family history of GC according to twenty-nine case-control studies and 1.83 (95%CI=1.67-2.01) from six cohort studies. The increased risk was higher in individuals with sibling history of GC than those with parental history of GC (RR=3.18, 95% CI=2.12-4.79 vs. RR=1.66, 95% CI=1.46-1.89, =0.021). For individuals with 2 or more first-degree relatives (FDRs) with GC, the RR was 2.81(95% CI=1.89-3.99). Subjects with both family history and infection confer a higher risk of GC (RR = 4.03, 95%CI=2.46-6.59).

CONCLUSION

The RR of GC among FDRs is lower than in previous studies. However, the risk of GC is markedly increased in individuals having a sibling with GC, more than 2 FDRs with GC. Intensified screening and eradication therapy for could be considered for these individuals.

摘要

背景

家族史可能会告知个体他们有患胃癌(GC)的风险。然而,对所有有胃癌家族史的个体进行强化筛查策略而非平均风险筛查,范围过于广泛。为了制定更精确的预防策略,对有胃癌家族史的个体进行准确的风险评估是必要的。

方法

我们检索了PubMed、EMBASE和Cochrane数据库,从其创建到2020年5月21日的所有相关研究,以查找调查胃癌家族史与其风险之间关联的队列研究和病例对照研究。使用随机效应或固定效应从研究中汇总相对风险(RR)和95%置信区间(CI)。

结果

根据29项病例对照研究,有胃癌家族史的个体患GC的RR为2.08(95%CI = 1.86 - 2.34),6项队列研究的结果为1.83(95%CI = 1.67 - 2.01)。有兄弟姐妹患GC病史的个体的风险增加高于有父母患GC病史的个体(RR = 3.18,95%CI = 2.12 - 4.79对比RR = 1.66,95%CI = 1.46 - 1.89,P = 0.021)。对于有2个或更多患GC的一级亲属(FDR)的个体,RR为2.81(95%CI = 1.89 - 3.99)。有家族史且感染的个体患GC的风险更高(RR = 4.03,95%CI = 2.46 - 6.59)。

结论

FDR中GC的RR低于先前研究。然而,有兄弟姐妹患GC、超过2个FDR患GC的个体患GC的风险显著增加。对于这些个体可考虑加强筛查和根除治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a099/9577147/85af9635ec28/IJPH-50-2384-g001.jpg

相似文献

2
Effects of Family History on Relative and Absolute Risks for Colorectal Cancer: A Systematic Review and Meta-Analysis.
Clin Gastroenterol Hepatol. 2019 Dec;17(13):2657-2667.e9. doi: 10.1016/j.cgh.2019.09.007. Epub 2019 Sep 13.
4
Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysis.
Gastric Cancer. 2019 May;22(3):435-445. doi: 10.1007/s10120-018-0876-0. Epub 2018 Sep 11.
5
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.
Gastroenterology. 2016 May;150(5):1113-1124.e5. doi: 10.1053/j.gastro.2016.01.028. Epub 2016 Feb 2.
6
Helicobacter pylori eradication therapy for functional dyspepsia: Systematic review and meta-analysis.
World J Gastroenterol. 2016 Mar 28;22(12):3486-95. doi: 10.3748/wjg.v22.i12.3486.
7
Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.
PLoS One. 2016 Oct 10;11(10):e0163743. doi: 10.1371/journal.pone.0163743. eCollection 2016.
8
Effect of Helicobacter pylori eradication on hyperplastic gastric polyps: A systematic review and meta-analysis.
Helicobacter. 2021 Oct;26(5):e12838. doi: 10.1111/hel.12838. Epub 2021 Jul 31.
9
Screening and eradication of for gastric cancer prevention: the Taipei global consensus.
Gut. 2020 Dec;69(12):2093-2112. doi: 10.1136/gutjnl-2020-322368. Epub 2020 Oct 1.
10
Optimum duration of regimens for Helicobacter pylori eradication.
Cochrane Database Syst Rev. 2013 Dec 11;2013(12):CD008337. doi: 10.1002/14651858.CD008337.pub2.

本文引用的文献

2
Family History of Gastric Cancer and Treatment.
N Engl J Med. 2020 Jan 30;382(5):427-436. doi: 10.1056/NEJMoa1909666.
4
6
Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism.
J Gastroenterol Hepatol. 2019 Aug;34(8):1287-1295. doi: 10.1111/jgh.14646. Epub 2019 Mar 27.
7
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.
Int J Cancer. 2019 Apr 15;144(8):1941-1953. doi: 10.1002/ijc.31937. Epub 2018 Dec 6.
8
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
9
Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western population.
Gastric Cancer. 2018 Sep;21(5):729-737. doi: 10.1007/s10120-018-0807-0. Epub 2018 Feb 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验